Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenofovir vs Lamivudine+Adefovir in Resistant CHB
NCT01732367Phase 4Completed
- Start
- Nov 2012
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tenofovir disoproxil fumarate in Chronic Hepatitis B (CHB) (2 arms). Primary endpoint: Percentage of patients with virus reactivation at Week 96. Started Nov 2012; status: completed.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01732367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01732367.